Epcoritamab (Epkinly) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

This PQI in Action is a follow up to the Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma PQI and explores how the medically integrated teams at Froedtert & Medical College of Wisconsin (Froedtert), Hematology-Oncology Associates of Central New York (HOA) and Mission Cancer + Blood collaborate and utilize the information found in the PQI as part of their daily practice.